ACADIA Pharmaceuticals
ACAD
#3710
Rank
C$5.22 B
Marketcap
C$30.22
Share price
0.82%
Change (1 day)
-2.99%
Change (1 year)

EPS for ACADIA Pharmaceuticals (ACAD)

EPS in 2023 (TTM): C-$1.25

According to ACADIA Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C$3.18. In 2022 the company made an earnings per share (EPS) of C-$1.89 a decrease over its 2021 EPS that were of C-$1.48.

EPS history for ACADIA Pharmaceuticals from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)C-$1.25-34.01%
2022C-$1.8927.62%
2021C-$1.48-41.67%
2020C-$2.5412.5%
2019C-$2.26-17.95%
2018C-$2.75-17.02%
2017C-$3.320.43%
2016C-$3.3043.56%
2015C-$2.3073.4%
2014C-$1.33113.64%
2013C-$0.6218.92%
2012C-$0.52-15.91%
2011C-$0.62-210%
2010C$0.56-133.61%
2009C-$1.68-30.81%
2008C-$2.437.5%
2007C-$2.26-0.62%
2006C-$2.274.55%
2005C-$2.17-14.61%
2004C-$2.55-84.26%
2003C-$16.18

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.44 197.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.07-66.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$43.58 1,271.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.38 100.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
C-$6.54-305.78%๐Ÿ‡บ๐Ÿ‡ธ USA